HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

After 5% Sales Growth In Its FY 2020, P&G Bullish For 2021 Despite Looming Economic Threats

Executive Summary

Macro factors that could hamper results include the economic recession caused by businesses’ reactions to novel coronavirus pandemic, the impact of COVID-19 on consumer buying trends and disruptions to supply chains.

You may also be interested in...



Colgate Passes Again On Offering Earnings Guidance Due To Market ‘Complexity, Volatility’

Colgate won’t provide full-year 2020 guidance even as the company reports 5.5% organic growth in the second quarter. Its sales in North America grew 24% on pandemic-related purchasing and price increases.

P&G’s Fourth Quarter Held Back By Grooming, Beauty, While Fabric & Home Care Cleans Up

Fabric & Home Care sales jumped 11% for the quarter, and Baby, Feminine & Family Care, 3%, reflecting consumer priorities during the COVID-19 pandemic. Beauty, impacted by travel retail’s nosedive, and Grooming, something consumers are doing considerably less of at home, were less impressive, but the units still grew in fiscal 2020 overall.

P&G Manages Production Demands 'Day To Day' As Consumer Health Brands Drive Growth In Pandemic

P&G reported personal health care brands drove overall health care organic sales up 9% to $2.26bn in its latest quarter. CFO Jon Moeller says consumer stockpiling caused production acceleration as its five largest North American plants in March increased production 22% over monthly average for previous year.

Topics

UsernamePublicRestriction

Register

LL1122113

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel